drugset / Trial / NCT01220869
A Study of Degarelix in Taiwanese Patients With Prostate Cancer
NaSingle-groupOpen-labelTreatment
Summary
A phase III trial investigating the efficacy and safety of degarelix one-month depot in Taiwanese patients with prostate cancer.
Timeline
- Start
- 2010-12
- Primary completion
- 2012-10
- Completion
- 2012-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Degarelix | Other / unclassified | 80 mg | Subcutaneous |